Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-16

Clinical Trial Update: AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer. [NA]

View source ↗

Summary

AURORA is a Breast International Group-sponsored study to understand molecular aberrations in metastatic breast cancer. It is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Breast International Group | Conditions: Metastatic Breast Cancer | NA | Status: RECRUITING